Hockessin, DE, United States of America

Naijing Su

USPTO Granted Patents = 8 

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Naijing Su

Introduction

Naijing Su is a prominent inventor based in Hockessin, Delaware, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio comprising six patents, Naijing has demonstrated a fervent commitment to innovation, particularly in the area of drug development for critical health issues.

Latest Patents

Among his notable contributions is the patent for a process of preparing a PD-1/PD-L1 inhibitor. This innovative process centers around the compound (R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2′-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, which possesses significant therapeutic potential for treating various diseases, including infections and cancers. Additionally, he has developed a patent related to processes and intermediates for preparing a JAK inhibitor, specifically focusing on baricitinib and its synthetic intermediate compounds. These inventions are pivotal in the ongoing quest to combat challenging diseases.

Career Highlights

Naijing Su is associated with Incyte Corporation, a leader in the biopharmaceutical sector. His role at the company has positioned him at the forefront of current pharmaceutical advancements, especially in the research and development of new therapies that address significant unmet medical needs.

Collaborations

Throughout his career, Naijing has collaborated with esteemed colleagues, including Jiacheng Zhou and Shili Chen. These collaborations highlight the importance of teamwork and collective expertise in driving successful innovations and enhancing the depth of research efforts within the field.

Conclusion

Naijing Su exemplifies the spirit of innovation through his dedicated work in the pharmaceutical industry. With a focus on developing inhibitors that could lead to groundbreaking treatments, he continues to pave the way for future advancements in medicine. His contributions not only reflect his expertise as an inventor but also his commitment to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…